Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 5543

1.

Diagnostic approach for patients with unidentified fever according to the classical criteria of fever of unknown origin in the field of autoimmune disorders.

Watanabe R, Sakuraba H, Hiraga H, Kishida D, Ota S, Hasui K, Kikuchi H, Akemoto Y, Tanaka N, Maeda T, Murai Y, Yoshida S, Tatsuta T, Sawaya M, Chinda D, Mikami T, Ishiguro Y, Fukuda S.

Immunol Med. 2019 Dec 1:1-9. doi: 10.1080/25785826.2019.1696631. [Epub ahead of print]

PMID:
31790331
2.

User-friendly cell patterning methods using a polydimethylsiloxane mold with microchannels.

Funano SI, Tanaka N, Tanaka Y.

Dev Growth Differ. 2019 Nov 21. doi: 10.1111/dgd.12637. [Epub ahead of print] Review.

PMID:
31755086
3.

Outcomes After Atrial Fibrillation Ablation in Patients With Premature Atrial Contractions Originating From Non-Pulmonary Veins.

Nakamaru R, Okada M, Tanaka N, Tanaka K, Ninomiya Y, Hirao Y, Oka T, Inoue H, Takayasu K, Koyama Y, Okamura A, Iwakura K, Rakugi H, Sakata Y, Fujii K, Inoue K.

JACC Clin Electrophysiol. 2019 Nov;5(11):1319-1327. doi: 10.1016/j.jacep.2019.08.002. Epub 2019 Oct 2.

PMID:
31753439
4.

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer.

Nakai Y, Tanaka N, Asakawa I, Torimoto K, Miyake M, Anai S, Fujii T, Hasegawa M, Fujimoto K.

J Contemp Brachytherapy. 2019 Oct;11(5):409-416. doi: 10.5114/jcb.2019.88142. Epub 2019 Oct 30.

5.

Biodiversity can benefit from climate stabilization despite adverse side effects of land-based mitigation.

Ohashi H, Hasegawa T, Hirata A, Fujimori S, Takahashi K, Tsuyama I, Nakao K, Kominami Y, Tanaka N, Hijioka Y, Matsui T.

Nat Commun. 2019 Nov 20;10(1):5240. doi: 10.1038/s41467-019-13241-y.

6.

Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease.

Kurihara S, Kimura T, Tanaka N, Yanagisawa T, Kobayashi H, Kanai K, Umemura T, Kobayashi M, Mori H, Wada S.

Clin J Gastroenterol. 2019 Nov 19. doi: 10.1007/s12328-019-01059-6. [Epub ahead of print]

PMID:
31745825
7.

Enzymatic Characteristics of a Polyphosphate/ATP-NAD Kinase, PanK, from Myxococcus xanthus.

Kimura Y, Kamimoto T, Tanaka N.

Curr Microbiol. 2019 Nov 18. doi: 10.1007/s00284-019-01810-9. [Epub ahead of print]

PMID:
31741028
8.

Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma.

Sugiyama Y, Gotoh O, Fukui N, Tanaka N, Hasumi K, Takazawa Y, Noda T, Mori S.

Am J Pathol. 2019 Nov 13. pii: S0002-9440(19)30798-9. doi: 10.1016/j.ajpath.2019.09.022. [Epub ahead of print]

PMID:
31733184
9.

Reduced Toxicity of Trichothecenes, Isotrichodermol, and Deoxynivalenol, by Transgenic Expression of the Tri101 3-O-Acetyltransferase Gene in Cultured Mammalian FM3A Cells.

Tanaka N, Takushima R, Tanaka A, Okada A, Matsui K, Maeda K, Aikawa S, Kimura M, Takahashi-Ando N.

Toxins (Basel). 2019 Nov 10;11(11). pii: E654. doi: 10.3390/toxins11110654.

10.

Long-term maintenance of the mucosal healing induced by azacitidine therapy in a patient with intestinal Behçet's-like disease accompanied with myelodysplastic syndrome involving trisomy 8.

Tanaka N, Sakuraba H, Hiraga H, Mayama K, Kikuchi H, Kishida D, Akemoto Y, Hasui K, Ota S, Watanabe R, Murai Y, Maeda T, Kamata K, Tatsuta T, Sawaya M, Chinda D, Mikami T, Yamagata K, Ishiguro Y, Tanaka M, Fukuda S.

Immunol Med. 2019 Sep;42(3):135-141. doi: 10.1080/25785826.2019.1687251. Epub 2019 Nov 9.

PMID:
31707933
11.

Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma.

Gotoh O, Sugiyama Y, Takazawa Y, Kato K, Tanaka N, Omatsu K, Takeshima N, Nomura H, Hasegawa K, Fujiwara K, Taki M, Matsumura N, Noda T, Mori S.

Nat Commun. 2019 Oct 31;10(1):4965. doi: 10.1038/s41467-019-12985-x.

12.

A multi E x B filter system for isotope enrichment application.

Leung KN, Tanaka N.

Appl Radiat Isot. 2020 Jan;155:108946. doi: 10.1016/j.apradiso.2019.108946. Epub 2019 Oct 17.

PMID:
31669952
13.

Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.

Nakai Y, Tanaka N, Asakawa I, Anai S, Miyake M, Morizawa Y, Hori S, Owari T, Fujii T, Yamaki K, Hasegawa M, Fujimoto K.

Jpn J Clin Oncol. 2019 Oct 28. pii: hyz136. doi: 10.1093/jjco/hyz136. [Epub ahead of print]

PMID:
31665354
14.

Transcatheter aortic valve implantation after aortic valve neocuspidization using autologous pericardium: a case report.

Tada N, Tanaka N, Abe K, Hata M.

Eur Heart J Case Rep. 2019 Jul 10;3(3):ytz105. doi: 10.1093/ehjcr/ytz105. eCollection 2019 Sep.

15.

A Case of Pulmonary Langerhans Cell Histiocytosis With Acute Progressive Nodular Lesions Depicted on High-Resolution Computed Tomography.

Kunihiro Y, Hara A, Ikeda E, Nakada N, Murakami T, Hayashi M, Okabe K, Yujiri T, Kamei H, Tanaka N, Onoda H, Matsumoto T, Ito K.

J Thorac Imaging. 2019 Nov;34(6):W144-W146. doi: 10.1097/RTI.0000000000000446. No abstract available.

PMID:
31658209
16.

Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy.

Kim CH, Koo BK, Dehbi HM, Lee JM, Doh JH, Nam CW, Shin ES, Cook CM, Al-Lamee R, Petraco R, Sen S, Malik IS, Nijjer SS, Mejía-Rentería H, Alegria-Barrero E, Alghamdi A, Altman J, Baptista SB, Bhindi R, Bojara W, Brugaletta S, Silva PC, Di Mario C, Erglis A, Gerber RT, Going O, Härle T, Hellig F, Indolfi C, Janssens L, Jeremias A, Kharbanda RK, Khashaba A, Kikuta Y, Krackhardt F, Laine M, Lehman SJ, Matsuo H, Meuwissen M, Niccoli G, Piek JJ, Ribichini F, Samady H, Sapontis J, Seto AH, Sezer M, Sharp ASP, Singh J, Takashima H, Talwar S, Tanaka N, Tang K, Van Belle E, van Royen N, Vinhas H, Vrints CJ, Walters D, Yokoi H, Samuels B, Buller C, Patel MR, Serruys PW, Escaned J, Davies JE.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2035-2046. doi: 10.1016/j.jcin.2019.06.035.

PMID:
31648764
17.

Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center.

Miyabe Y, Karasawa K, Takabe T, Ogura S, Sugiura N, Kyoda M, Ono W, Akiyama K, Tanaka N, Moriyama T, Hanafusa N, Uchida K, Tuchiya K, Nitta K.

Clin Exp Nephrol. 2019 Oct 22. doi: 10.1007/s10157-019-01799-2. [Epub ahead of print]

PMID:
31641958
18.

[A Case of Rectal Cancers with Pneumonia Combined with Interesting Body Pressure Distribution Before and after Treatment].

Kageyama E, Nakayama T, Tanaka N.

Gan To Kagaku Ryoho. 2019 Oct;46(10):1587-1590. Japanese.

PMID:
31631145
19.
20.

Nivolumab-induced cholangitis in patients with non-small cell lung cancer: Case series and a review of literature.

Izumi H, Kodani M, Kurai J, Takeda K, Okazaki R, Yamane K, Teruya Y, Yamamoto A, Sueda Y, Yanai M, Tanaka N, Sakamoto T, Yamaguchi K, Makino H, Igishi T, Yamasaki A.

Mol Clin Oncol. 2019 Nov;11(5):439-446. doi: 10.3892/mco.2019.1923. Epub 2019 Sep 18.

21.

A case of celiac disease with type I enteropathy-associated T-cell lymphoma in a Japanese male patient.

Hiraga H, Sakuraba H, Tanaka N, Watanabe R, Akemoto Y, Ota S, Kikuchi H, Sawaya M, Hiraga N, Chinda D, Hanabata N, Mikami T, Shimoyama T, Takahata T, Tanaka M, Fukuda S.

Immunol Med. 2019 Sep;42(3):142-147. doi: 10.1080/25785826.2019.1673031. Epub 2019 Oct 11.

PMID:
31603739
22.

Hypascyrins A-E, Prenylated Acylphloroglucinols from Hypericum ascyron.

Niwa K, Tanaka N, Tatano Y, Yagi H, Kashiwada Y.

J Nat Prod. 2019 Oct 25;82(10):2754-2760. doi: 10.1021/acs.jnatprod.9b00354. Epub 2019 Oct 9.

PMID:
31596079
23.

Temporal trends in the prevalence of albuminuria and reduced eGFR in Japanese patients with type 2 diabetes.

Tanaka N, Yamamoto Y, Yokoyama Y, Mori T, Hanai K, Babazono T.

Diabetol Int. 2019 Mar 15;10(4):279-287. doi: 10.1007/s13340-019-00392-y. eCollection 2019 Oct.

PMID:
31592404
24.

Soft Windowing Application to Improve Analysis of High-throughput Phenotyping Data.

Haselimashhadi H, Mason JC, Munoz-Fuentes V, López-Gómez F, Babalola K, Acar EF, Kumar V, White J, Flenniken AM, King R, Straiton E, Seavitt JR, Gaspero A, Garza A, Christianson AE, Hsu CW, Reynolds CL, Lanza DG, Lorenzo I, Green JR, Gallegos JJ, Bohat R, Samaco RC, Veeraragavan S, Kim JK, Miller G, Fuchs H, Garrett L, Becker L, Kang YK, Clary D, Cho SY, Tamura M, Tanaka N, Soo KD, Bezginov A, About GB, Champy MF, Vasseur L, Leblanc S, Meziane H, Selloum M, Reilly PT, Spielmann N, Maier H, Gailus-Durner V, Sorg T, Hiroshi M, Yuichi O, Heaney JD, Dickinson ME, Wolfgang W, Tocchini-Valentini GP, Lloyd KCK, McKerlie C, Seong JK, Yann H, de Angelis MH, Brown SDM, Smedley D, Flicek P, Mallon AM, Parkinson H, Meehan TF.

Bioinformatics. 2019 Oct 8. pii: btz744. doi: 10.1093/bioinformatics/btz744. [Epub ahead of print]

PMID:
31591642
25.

[Multilocular Thymic Cyst with Calcification;Report of a Case].

Matsui H, Taniguchi Y, Saito T, Hino H, Tanaka N, Tsuta K, Murakawa T.

Kyobu Geka. 2019 Oct;72(11):962-965. Japanese.

PMID:
31588118
26.

Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".

Murasawa H, Sugiyama T, Matsuoka Y, Okabe T, Wakumoto Y, Tanaka N, Sugimoto M, Oyama M, Fujimoto K, Horie S, Funagoshi M, Arakawa I, Noto S, Shimozuma K.

Qual Life Res. 2019 Oct 3. doi: 10.1007/s11136-019-02316-4. [Epub ahead of print]

PMID:
31583618
27.

Two-stage goal-directed therapy protocol for non-donor open hepatectomy: an interventional before-after study.

Mizunoya K, Fujii T, Yamamoto M, Tanaka N, Morimoto Y.

J Anesth. 2019 Dec;33(6):656-664. doi: 10.1007/s00540-019-02688-4. Epub 2019 Oct 3.

PMID:
31583432
28.

Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).

Misawa K, Mochizuki Y, Sakai M, Teramoto H, Morimoto D, Nakayama H, Tanaka N, Matsui T, Ito Y, Ito S, Tanaka K, Uemura K, Morita S, Kodera Y; Chubu Clinical Oncology Group.

Br J Surg. 2019 Nov;106(12):1602-1610. doi: 10.1002/bjs.11303. Epub 2019 Oct 1.

PMID:
31573086
29.

Effects of L-DOPA on quadripulse magnetic stimulation-induced long-term potentiation in older adults.

Tanaka N, Tsutsumi R, Shirota Y, Shimizu T, Ohminami S, Terao Y, Ugawa Y, Tsuji S, Hanajima R.

Neurobiol Aging. 2019 Aug 9. pii: S0197-4580(19)30283-0. doi: 10.1016/j.neurobiolaging.2019.08.005. [Epub ahead of print]

PMID:
31570179
30.

Validity of noninvasive central aortic pressure measurement.

O'Rourke MF, Takazawa K, Tanaka N.

J Hypertens. 2019 Nov;37(11):2300-2301. doi: 10.1097/HJH.0000000000002211. No abstract available.

PMID:
31567758
31.

Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy.

Matsumoto K, Niwa N, Hagiwara M, Kosaka T, Tanaka N, Takeda T, Morita S, Mizuno R, Shinojima T, Hara S, Asanuma H, Oya M.

World J Urol. 2019 Sep 26. doi: 10.1007/s00345-019-02970-w. [Epub ahead of print]

PMID:
31559475
32.

Low-dose-rate brachytherapy for prostate cancer: A 15-year experience in Japan.

Tanaka N, Asakawa I, Hasegawa M, Fujimoto K.

Int J Urol. 2019 Sep 24. doi: 10.1111/iju.14098. [Epub ahead of print] Review.

PMID:
31549770
33.

Fragment-based discovery of the first nonpeptidyl inhibitor of an S46 family peptidase.

Sakamoto Y, Suzuki Y, Nakamura A, Watanabe Y, Sekiya M, Roppongi S, Kushibiki C, Iizuka I, Tani O, Sakashita H, Inaka K, Tanaka H, Yamada M, Ohta K, Honma N, Shida Y, Ogasawara W, Nakanishi-Matsui M, Nonaka T, Gouda H, Tanaka N.

Sci Rep. 2019 Sep 19;9(1):13587. doi: 10.1038/s41598-019-49984-3.

34.

Identification of IscU residues critical for de novo iron-sulfur cluster assembly.

Tanaka N, Yuda E, Fujishiro T, Hirabayashi K, Wada K, Takahashi Y.

Mol Microbiol. 2019 Sep 18. doi: 10.1111/mmi.14392. [Epub ahead of print]

PMID:
31532036
35.

Impact of baseline left atrial function on long-term outcome after catheter ablation for paroxysmal atrial fibrillation.

Oka T, Tanaka K, Ninomiya Y, Hirao Y, Tanaka N, Okada M, Inoue H, Takayasu K, Kitagaki R, Koyama Y, Okamura A, Iwakura K, Sakata Y, Fujii K, Inoue K.

J Cardiol. 2019 Sep 11. pii: S0914-5087(19)30275-8. doi: 10.1016/j.jjcc.2019.08.014. [Epub ahead of print]

PMID:
31521450
36.

Mechanism of high folate accumulation in a sake yeast other than Kyokai yeasts.

Shibata Y, Yamada T, Morimoto T, Fujii T, Akao T, Goshima T, Takahashi T, Tanaka N.

J Biosci Bioeng. 2019 Sep 9. pii: S1389-1723(19)30477-3. doi: 10.1016/j.jbiosc.2019.07.008. [Epub ahead of print]

PMID:
31515157
37.

[Successful Multidisciplinary Treatment Accomplished by Collaboration of Multiple Clinical Departments for Synchronous Quadruple Cancer].

Eba S, Notsuda H, Hoshi F, Oishi H, Matsuda Y, Sado T, Noda M, Sakurada A, Saijo K, Okoshi A, Tanaka N, Okada Y.

Kyobu Geka. 2019 Sep;72(9):655-657. Japanese.

PMID:
31506404
38.

A Potential Application of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with Photodynamic Diagnosis for the Detection of Bladder Carcinoma in Situ: Toward the Future 'MRI-PDD Fusion TURBT'.

Miyake M, Maesaka F, Marugami N, Miyamoto T, Nakai Y, Ohnishi S, Gotoh D, Owari T, Hori S, Morizawa Y, Itami Y, Inoue T, Anai S, Torimoto K, Fujii T, Shimada K, Tanaka N, Fujimoto K.

Diagnostics (Basel). 2019 Sep 4;9(3). pii: E112. doi: 10.3390/diagnostics9030112.

39.

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis.

Inada R, Miyamoto K, Tanaka N, Moriguchi K, Kusunoki S.

Intern Med. 2019 Sep 3. doi: 10.2169/internalmedicine.3030-19. [Epub ahead of print]

40.

DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death.

Itoh K, Ebata T, Hirata H, Torii T, Sugimoto W, Onodera K, Nakajima W, Uehara I, Okuzaki D, Yamauchi S, Budirahardja Y, Nishikata T, Tanaka N, Kawauchi K.

Molecules. 2019 Sep 1;24(17). pii: E3175. doi: 10.3390/molecules24173175.

41.

Breast-conserving surgery without radiation in elderly women with early breast cancer.

Inoue H, Hirano A, Ogura K, Kamimura M, Hattori A, Yukawa H, Sakaguchi S, Tanaka N, Matsuoka A, Kodera A, Shimizu T.

Surg Oncol. 2019 Dec;31:22-25. doi: 10.1016/j.suronc.2019.08.008. Epub 2019 Aug 22.

PMID:
31479976
42.

Cognitive burden and polypharmacy in elderly Japanese patients treated with anticholinergics for an overactive bladder.

Shiota T, Torimoto K, Okuda M, Iwata R, Kumamoto H, Miyake M, Hirayama A, Tanaka N, Fujimoto K.

Low Urin Tract Symptoms. 2019 Aug 28. doi: 10.1111/luts.12285. [Epub ahead of print]

PMID:
31460706
43.

Plasticity induction in the pre-supplementary motor area (pre-SMA) and SMA-proper differentially affects visuomotor sequence learning.

Shimizu T, Hanajima R, Shirota Y, Tsutsumi R, Tanaka N, Terao Y, Hamada M, Ugawa Y.

Brain Stimul. 2020 Jan - Feb;13(1):229-238. doi: 10.1016/j.brs.2019.08.001. Epub 2019 Aug 6.

44.

Urinary nerve growth factor can predict therapeutic efficacy in children with monosymptomatic nocturnal enuresis.

Morizawa Y, Aoki K, Iemura Y, Hori S, Gotoh D, Fukui S, Nakai Y, Miyake M, Torimoto K, Tanaka N, Fujimoto K.

Neurourol Urodyn. 2019 Nov;38(8):2311-2317. doi: 10.1002/nau.24142. Epub 2019 Aug 20.

PMID:
31432572
45.

Involvement of H+-gradient dependent transporter in PGE2 release from A549 cells.

Tanaka N, Yamaguchi H, Mano N.

Prostaglandins Leukot Essent Fatty Acids. 2019 Oct;149:30-36. doi: 10.1016/j.plefa.2019.08.003. Epub 2019 Aug 8.

PMID:
31421525
46.

Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients.

Tanaka J, Tanaka N, Wang YH, Mitsuhashi K, Ryuzaki M, Iizuka Y, Watanabe A, Ishiyama M, Shinohara A, Kazama H, Hagiwara S, Yoshinaga K, Kougen Y, Kobayashi H, Kanno H, Shiseki M.

Haematologica. 2019 Aug 8. pii: haematol.2019.226696. doi: 10.3324/haematol.2019.226696. [Epub ahead of print]

47.

Evaluation of Preoperative Abdominal Adipose Tissue-, Inflammation-, Muscle Mass-, and Nutritional Status-based Prognostic Markers to Assess Renal Dysfunction in Living Kidney Donors.

Hori S, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Miyake M, Anai S, Torimoto K, Aoki K, Yoneda T, Tanaka N, Yoshida K, Fujimoto K.

Transplant Proc. 2019 Jul - Aug;51(6):1706-1716. doi: 10.1016/j.transproceed.2019.04.057.

PMID:
31399161
48.

Supplementary granulocyte macrophage colony-stimulating factor to chemotherapy and programmed death-ligand 1 blockade decreases local recurrence after surgery in bladder cancer.

Miyake M, Hori S, Ohnishi S, Toritsuka M, Fujii T, Shimizu T, Owari T, Morizawa Y, Gotoh D, Itami Y, Nakai Y, Anai S, Torimoto K, Tanaka N, Fujimoto K.

Cancer Sci. 2019 Oct;110(10):3315-3327. doi: 10.1111/cas.14158. Epub 2019 Aug 19.

49.

First molecular phylogenetic insights into the evolution of Eriocaulon (Eriocaulaceae, Poales).

Larridon I, Tanaka N, Liang Y, Phillips SM, Barfod AS, Cho SH, Gale SW, Jobson RW, Kim YD, Li J, Muasya AM, Parnell JAN, Prajaksood A, Shutoh K, Souladeth P, Tagane S, Tanaka N, Yano O, Mesterházy A, Newman MF, Ito Y.

J Plant Res. 2019 Sep;132(5):589-600. doi: 10.1007/s10265-019-01129-3. Epub 2019 Aug 5.

50.

The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions.

Miyake M, Tanaka N, Asakawa I, Owari T, Hori S, Morizawa Y, Nakai Y, Inoue T, Anai S, Torimoto K, Hasegawa M, Fujii T, Konishi N, Fujimoto K.

Prostate Int. 2019 Jun;7(2):47-53. doi: 10.1016/j.prnil.2018.04.005. Epub 2018 May 5.

Supplemental Content

Loading ...
Support Center